company-logo

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Elevation Oncology Dividend Announcement

Elevation Oncology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Elevation Oncology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Elevation Oncology Dividend History

Elevation Oncology Dividend Yield

Elevation Oncology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Elevation Oncology stock? Use our calculator to estimate your expected dividend yield:

Elevation Oncology Financial Ratios

P/E ratio-0.91
PEG ratio0.01
P/B ratio0.55
ROE-59.73%
Payout ratio0.00%
Current ratio17.77
Quick ratio17.77
Cash Ratio8.13

Elevation Oncology Dividend FAQ

Does Elevation Oncology stock pay dividends?
Elevation Oncology does not currently pay dividends to its shareholders.
Has Elevation Oncology ever paid a dividend?
No, Elevation Oncology has no a history of paying dividends to its shareholders. Elevation Oncology is not known for its dividend payments.
Why doesn't Elevation Oncology pay dividends?
There are several potential reasons why Elevation Oncology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Elevation Oncology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Elevation Oncology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Elevation Oncology a dividend aristocrat?
Elevation Oncology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Elevation Oncology a dividend king?
Elevation Oncology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Elevation Oncology a dividend stock?
No, Elevation Oncology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Elevation Oncology stocks?
To buy Elevation Oncology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Elevation Oncology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.